Georgia Bio Blog

Our Top Three Requests of Georgia’s U.S. Congressional Leadership

April 19, 2019

At the 2019 Biotechnology Innovation Organization (BIO) DC Fly-In more than 200 biotechnology and life science industry leaders from across the U.S. convened in the District of Columbia to meet with members of Congress and staff to discuss key legislative priorities important to our industry. Georgia Bio had the pleasure of meeting with our senators…

Read More

Georgia Bio Quarterly Meeting: State of the Industry Report

April 11, 2019

April 17, 2019 | 7:30 – 9:00AM Upstairs Atlanta, 525 Bishop St NW, Atlanta, GA 30318 Join Georgia Bio for a preview of the 2019 Georgia Life Sciences Industry Analysis. This breakfast meeting will provide members, non-members and Georgia community leaders with valuable industry information. The state of the industry report, supported by funding from…

Read More

What are the most exciting opportunities in cardiovascular innovation? Part 2 of our interview with Dr. Richard Hillstead

April 8, 2019

Strokes and cardiovascular disease are taking far too many lives says Dr. Richard Hillstead. These medical issues are ripe for innovation, particularly in minimally invasive opportunities that shorten or eliminate hospital stays while improving patient outcomes. And what about genomics? “I question whether we are as morally and ethically advanced as we are scientifically and…

Read More

What are the top things new life science innovators need to know? Decorated cardiology researcher and innovator Dr. Richard Hillstead tells us.

April 8, 2019

Dr. Richard Hillstead is both a medtech innovator and a fellow in the American Heart Association on the Council of Clinical Cardiology. He has practiced on the front lines of patient care and life science innovation for decades. Dr. Hillstead, a recipient of a 2019 Industry Growth Award, Georgia Bio’s highest honor, spoke with Write2Market…

Read More

Life science and legislative convergence: 4 questions with Arbor Pharmaceutical CEO Ed Schutter

April 1, 2019

With the 2019 Georgia legislative session in full swing and potentially game changing recent comments from U.S. Health and Human Services Secretary Alex Azar, Paul Snyder, VP of Healthcare for Georgia Bio partner Write2Market spoke with Arbor Pharmaceutical CEO Ed Schutter about what the life sciences industry needs from state policy makers in 2019. Paul:…

Read More

Top issues from 2019 AdvaMed Washington Fly In and what they mean to Georgia’s life science community

March 15, 2019

Two weeks ago, Georgia Bio VP of Business Development and External Affairs Joseph Santoro participated in a Washington fly in to discuss, educate and learn from Congressional legislators, lobbyists and other industry colleagues about the medtech policy climate in the nation’s capital. He shares with us the following top takeaways as formally shared by AdvaMed…

Read More

Quick Clip Interview: Two minutes with Dr. Jay Yadav

March 13, 2019

With the development, commercialization and eventual $450 million sale of CardioMEMS, Dr. Jay Yadav demonstrated the magnitude of what is possible in Georgia’s medtech and life sciences ecosystem. Fast forward more than five years and we find him at the helm of MiRus, LLC. MiRus “is focused on the design of innovative solutions for treatment…

Read More

Video Interview: GRA President Russell Allen on the state and needs of Georgia’s life science community – Part 2 of 2

March 6, 2019

By funding research, recruiting scholars, translational and commercialization efforts, GRA plays an integral role in the state’s life science innovation capabilities and industry growth. 2019 will mark the 10th anniversary of the GRA Venture Fund, a public – private venture capital fund that invests in research driven, Georgia-based companies. “We need to introduce [new legislators]…

Read More

Video Interview: Russell Allen on GRA’s life science innovation and research funding activities – Part 1 of 2

March 6, 2019

Russell Allen recently transitioned from leading Georgia Bio to leading the Georgia Research Alliance. He also received one of two Georgia Bio 2019 Industry Growth Awards, the highest honor the organization bestows upon industry leaders. “We will be asking the state for additional support to help further grow innovation and home grown economic development in…

Read More

Video Interview: “We are ultimately supporting our economy and our students in identifying high paying jobs in the life sciences sector.”

March 1, 2019

A state’s life science industry is only as robust as its available workforce. During the 2019 Georgia Bio Golden Helix Awards Gala, Chuck Fogelgren shared his thoughts on STEM education, public – private partnerships, precision medicine, data and the Georgia ecosystem. “[Our teacher training program] is specifically designed to help prepare these students to enter…

Read More